Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Science is best communicated through identity and culture – how researchers are ensuring STEM serves their communities - 2Instructions to Explore the Universe of Vehicle Leases
- 3Grass Care Administrations for a Wonderful, Sound Yard
- 4Orcas seen hunting great white sharks to eat their livers in drone footage recorded in Mexico
- 5Artemis 2 moon rocket gets 'America 250' paint job | Space photo of the day for Dec. 23, 2025
- Vote In favor of Your Favored Language Interpretation Administration
- Figure out How to Get the Most Familiar Drive for Seniors in SUVs
- Hundreds are quarantined in South Carolina as measles spreads in 2 US outbreaks
- Study shows no clear link between low-fat dairy and dementia risk
- People are getting their news from AI – and it’s altering their views
- Innospace's rocket crashes in first commercial launch in Brazil; shares tumble
- They relied on marijuana to get through the day. But then days felt impossible without it
- King Charles III says he is reducing cancer treatment schedule in 2026
- Public mistrust linked to drop in deceased donor organ donations and kidney transplants
